Request for Covid-19 Impact Assessment of this Report
Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Budesonide (BUD) for these regions, from 2012 to 2022 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India
Global Budesonide (BUD) market competition by top manufacturers/players, with Budesonide (BUD) sales volume, Price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical
On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Nasal Spray
Inhaler
Pill&Rectal Forms
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Budesonide (BUD) for each application, including
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
If you have any special requirements, please let us know and we will offer you the report as you want.
Global Budesonide (BUD) Sales Market Report 2017
1 Budesonide (BUD) Market Overview
1.1 Product Overview and Scope of Budesonide (BUD)
1.2 Classification of Budesonide (BUD) by Product Category
1.2.1 Global Budesonide (BUD) Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 Global Budesonide (BUD) Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Nasal Spray
1.2.4 Inhaler
1.2.5 Pill&Rectal Forms
1.3 Global Budesonide (BUD) Market by Application/End Users
1.3.1 Global Budesonide (BUD) Sales (Volume) and Market Share Comparison by Application (2012-2022)
1.3.2 Respiratory Disease Treatment
1.3.3 Nose Disease Treatment
1.3.4 Inflammatory Bowel Disease Treatment
1.4 Global Budesonide (BUD) Market by Region
1.4.1 Global Budesonide (BUD) Market Size (Value) Comparison by Region (2012-2022)
1.4.2 United States Budesonide (BUD) Status and Prospect (2012-2022)
1.4.3 China Budesonide (BUD) Status and Prospect (2012-2022)
1.4.4 Europe Budesonide (BUD) Status and Prospect (2012-2022)
1.4.5 Japan Budesonide (BUD) Status and Prospect (2012-2022)
1.4.6 Southeast Asia Budesonide (BUD) Status and Prospect (2012-2022)
1.4.7 India Budesonide (BUD) Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Budesonide (BUD) (2012-2022)
1.5.1 Global Budesonide (BUD) Sales and Growth Rate (2012-2022)
1.5.2 Global Budesonide (BUD) Revenue and Growth Rate (2012-2022)
2 Global Budesonide (BUD) Competition by Players/Suppliers, Type and Application
2.1 Global Budesonide (BUD) Market Competition by Players/Suppliers
2.1.1 Global Budesonide (BUD) Sales and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Global Budesonide (BUD) Revenue and Share by Players/Suppliers (2012-2017)
2.2 Global Budesonide (BUD) (Volume and Value) by Type
2.2.1 Global Budesonide (BUD) Sales and Market Share by Type (2012-2017)
2.2.2 Global Budesonide (BUD) Revenue and Market Share by Type (2012-2017)
2.3 Global Budesonide (BUD) (Volume and Value) by Region
2.3.1 Global Budesonide (BUD) Sales and Market Share by Region (2012-2017)
2.3.2 Global Budesonide (BUD) Revenue and Market Share by Region (2012-2017)
2.4 Global Budesonide (BUD) (Volume) by Application
3 United States Budesonide (BUD) (Volume, Value and Sales Price)
3.1 United States Budesonide (BUD) Sales and Value (2012-2017)
3.1.1 United States Budesonide (BUD) Sales and Growth Rate (2012-2017)
3.1.2 United States Budesonide (BUD) Revenue and Growth Rate (2012-2017)
3.1.3 United States Budesonide (BUD) Sales Price Trend (2012-2017)
3.2 United States Budesonide (BUD) Sales Volume and Market Share by Players
3.3 United States Budesonide (BUD) Sales Volume and Market Share by Type
3.4 United States Budesonide (BUD) Sales Volume and Market Share by Application
4 China Budesonide (BUD) (Volume, Value and Sales Price)
4.1 China Budesonide (BUD) Sales and Value (2012-2017)
4.1.1 China Budesonide (BUD) Sales and Growth Rate (2012-2017)
4.1.2 China Budesonide (BUD) Revenue and Growth Rate (2012-2017)
4.1.3 China Budesonide (BUD) Sales Price Trend (2012-2017)
4.2 China Budesonide (BUD) Sales Volume and Market Share by Players
4.3 China Budesonide (BUD) Sales Volume and Market Share by Type
4.4 China Budesonide (BUD) Sales Volume and Market Share by Application
5 Europe Budesonide (BUD) (Volume, Value and Sales Price)
5.1 Europe Budesonide (BUD) Sales and Value (2012-2017)
5.1.1 Europe Budesonide (BUD) Sales and Growth Rate (2012-2017)
5.1.2 Europe Budesonide (BUD) Revenue and Growth Rate (2012-2017)
5.1.3 Europe Budesonide (BUD) Sales Price Trend (2012-2017)
5.2 Europe Budesonide (BUD) Sales Volume and Market Share by Players
5.3 Europe Budesonide (BUD) Sales Volume and Market Share by Type
5.4 Europe Budesonide (BUD) Sales Volume and Market Share by Application
6 Japan Budesonide (BUD) (Volume, Value and Sales Price)
6.1 Japan Budesonide (BUD) Sales and Value (2012-2017)
6.1.1 Japan Budesonide (BUD) Sales and Growth Rate (2012-2017)
6.1.2 Japan Budesonide (BUD) Revenue and Growth Rate (2012-2017)
6.1.3 Japan Budesonide (BUD) Sales Price Trend (2012-2017)
6.2 Japan Budesonide (BUD) Sales Volume and Market Share by Players
6.3 Japan Budesonide (BUD) Sales Volume and Market Share by Type
6.4 Japan Budesonide (BUD) Sales Volume and Market Share by Application
7 Southeast Asia Budesonide (BUD) (Volume, Value and Sales Price)
7.1 Southeast Asia Budesonide (BUD) Sales and Value (2012-2017)
7.1.1 Southeast Asia Budesonide (BUD) Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Budesonide (BUD) Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Budesonide (BUD) Sales Price Trend (2012-2017)
7.2 Southeast Asia Budesonide (BUD) Sales Volume and Market Share by Players
7.3 Southeast Asia Budesonide (BUD) Sales Volume and Market Share by Type
7.4 Southeast Asia Budesonide (BUD) Sales Volume and Market Share by Application
8 India Budesonide (BUD) (Volume, Value and Sales Price)
8.1 India Budesonide (BUD) Sales and Value (2012-2017)
8.1.1 India Budesonide (BUD) Sales and Growth Rate (2012-2017)
8.1.2 India Budesonide (BUD) Revenue and Growth Rate (2012-2017)
8.1.3 India Budesonide (BUD) Sales Price Trend (2012-2017)
8.2 India Budesonide (BUD) Sales Volume and Market Share by Players
8.3 India Budesonide (BUD) Sales Volume and Market Share by Type
8.4 India Budesonide (BUD) Sales Volume and Market Share by Application
9 Global Budesonide (BUD) Players/Suppliers Profiles and Sales Data
9.1 AstraZeneca
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Budesonide (BUD) Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 AstraZeneca Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 Cosmo Pharmaceuticals
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Budesonide (BUD) Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Teva
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Budesonide (BUD) Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Teva Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 Mylan
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Budesonide (BUD) Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Mylan Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Sandoz
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Budesonide (BUD) Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Sandoz Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 Dr. Falk Pharma
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Budesonide (BUD) Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Dr. Falk Pharma Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Chiesi Farmaceutici S.p.A
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Budesonide (BUD) Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Chiesi Farmaceutici S.p.A Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Orion Corporation
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Budesonide (BUD) Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Orion Corporation Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview
9.9 Cipla
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Budesonide (BUD) Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 Cipla Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.9.4 Main Business/Business Overview
9.10 Synmosa Biopharma Corporation
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Budesonide (BUD) Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Synmosa Biopharma Corporation Budesonide (BUD) Sales, Revenue, Price and Gross Margin (2012-2017)
9.10.4 Main Business/Business Overview
9.11 Lunan Better Pharmaceutical
9.12 Shanghai Sine Promod Pharmaceutical
10 Budesonide (BUD) Maufacturing Cost Analysis
10.1 Budesonide (BUD) Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Budesonide (BUD)
10.3 Manufacturing Process Analysis of Budesonide (BUD)
11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Budesonide (BUD) Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Budesonide (BUD) Major Manufacturers in 2016
11.4 Downstream Buyers
12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change
14 Global Budesonide (BUD) Market Forecast (2017-2022)
14.1 Global Budesonide (BUD) Sales Volume, Revenue and Price Forecast (2017-2022)
14.1.1 Global Budesonide (BUD) Sales Volume and Growth Rate Forecast (2017-2022)
14.1.2 Global Budesonide (BUD) Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Budesonide (BUD) Price and Trend Forecast (2017-2022)
14.2 Global Budesonide (BUD) Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
14.2.1 Global Budesonide (BUD) Sales Volume and Growth Rate Forecast by Regions (2017-2022)
14.2.2 Global Budesonide (BUD) Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.3 United States Budesonide (BUD) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 China Budesonide (BUD) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Europe Budesonide (BUD) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 Japan Budesonide (BUD) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.7 Southeast Asia Budesonide (BUD) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.2.8 India Budesonide (BUD) Sales Volume, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Budesonide (BUD) Sales Volume, Revenue and Price Forecast by Type (2017-2022)
14.3.1 Global Budesonide (BUD) Sales Forecast by Type (2017-2022)
14.3.2 Global Budesonide (BUD) Revenue Forecast by Type (2017-2022)
14.3.3 Global Budesonide (BUD) Price Forecast by Type (2017-2022)
14.4 Global Budesonide (BUD) Sales Volume Forecast by Application (2017-2022)
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...